Out-of-pock­et cap will in­crease the net price of in­sulin, CBO tells Sen­ate bill spon­sors

A bill that would cap out-of-pock­et in­sulin costs for the in­sured at $35 per month re­mains in lim­bo as the Con­gres­sion­al Bud­get Of­fice told the two Sen­ate spon­sors of the bill that it will like­ly in­crease net prices for in­sulin, and will in­crease pre­mi­ums for com­mer­cial health in­sur­ance and Medicare Part D.

The com­ments from the CBO may spell the end for the bill, which is ef­fec­tive­ly a Band-Aid for a seg­ment of the phar­ma mar­ket that has bal­looned in re­cent years, dri­ving many to ra­tion their life-sav­ing drug.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.